Journal Mobile Options
Table of Contents
Vol. 38, No. 6, 2006
Issue release date: November 2006
Ophthalmic Res 2006;38:318–323

Intraocular Lens Implantation in Patients with Juvenile Idiopathic Arthritis-Associated Uveitis

Kotaniemi K. · Penttilä H.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: To evaluate the development of cataract and the results of cataract surgery with intraocular lens (IOL) implantation in patients with chronic uveitis associated with juvenile idiopathic arthritis (JIA). Patients and Methods: A hospital-based retrospective case series consisted of 25 patients with JIA-associated uveitis. The mean age of the patients was 5.8 years at the onset of arthritis and 6.8 years at the onset of uveitis. During the 15-year study period cataract surgery with implantation of an IOL was performed in 36 eyes. In 17 eyes phacoemulsification and initial posterior capsulectomy with anterior core vitrectomy were performed. The treatment of JIA and uveitis was carefully adjusted with systemic immunosuppressive drugs and topical corticosteroids perioperatively. The mean postoperative follow-up period was 3.3 years. Results: The first signs of cataract were observed 2.3 years (mean) after the diagnosis of uveitis and the cataract operation of the first eye was performed 4.5 years (mean) after the diagnosis of uveitis. After IOL surgery the visual result was good (≧0.5) in 64%, moderate (0.3 to <0.5) in 11% and impaired (<0.3) in 25% of eyes. Secondary cataract developed in 16 eyes but in none of the eyes with initial posterior capsulectomy and core vitrectomy. Secondary glaucoma developed in 18 eyes, retinal detachment in 2, cystoid macular edema in 16 and band keratopathy in 12 eyes. Conclusion: Cataract is an early complication of JIA-associated uveitis. Under strict control of uveitis, IOL implantation is an important alternative in visual rehabilitation for this type of patient.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Petty RE, Southwood TR: Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991–1994.
  2. Kanski JJ: Juvenile arthritis and uveitis. Surv Ophthalmol 1990;34:253–267.
  3. Kotaniemi K, Savolainen A, Karma A, Aho K: Recent advances in uveitis of juvenile idiopathic arthritis: major review. Surv Ophthalmol 2003;48:489–502.
  4. Kanski JJ: Uveitis in juvenile chronic arthritis: incidence, clinical features and prognosis. Eye 1984;2:641–645.
  5. Hooper PL, Rao NA, Smith RE: Cataract extraction in uveitis patients. Surv Ophthalmol 1990;35:120–144.
  6. Okhravi N, Lightman SL, Towler HMA: Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology 1999;106:710–722.
  7. Estafanous MFG, Lowder CY, Meisler DM, Chauhan R: Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol 2001;131:620–625.
  8. Foster CS, Barrett F: Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology 1993;100:809–817.
  9. Probst LE, Holland EJ: Intraocular lens implantation in patients with juvenile rheumatoid arthritis. Am J Ophthalmol 1996;122:161–170.
  10. BenEzra D, Cohen E: Cataract surgery in children with chronic uveitis. Ophthalmology 2000;107:1255–1260.
  11. Lundvall A, Zetterström C: Cataract extraction and intraocular lens implantation in children with uveitis. Br J Ophthalmol 2000;84:791–793.
  12. Lam LA, Lowder CY, Baerweldt G, Smith SD, Traboulsi EI: Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis. Am J Ophthalmol 2003;135:772–778.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50